Navigation Links
Drugs.com Releases Q4 Sales for Top 100 U.S. Drugs
Date:2/13/2013

NEW YORK, Feb. 13, 2013 /PRNewswire/ -- Drugs.com, the leading online clinical drug resource, today released fourth quarter 2012 U.S. prescription sales data for the top 100 drugs.

At the close of 2012, Otsuka's antipsychotic Abilify overtakes AstraZeneca's acid reducer Nexium and moves into the number one spot with over $1.47 billion in quarterly sales. Sales expanded for all five front-runners over the quarter, although none reached double-digit growth. There are no changes in the top selling pharmaceutical classes, which include antipsychotics, proton pump inhibitors, and statins.Top Five Drugs by Sales, Q4 2012Drug Name  

Gain ($000)  

% Change (previous quarter)budesonide$79,295

+42.52%Abilify$73,075

+5.20%Cymbalta$69,131

+5.97%Lantus Solostar

$62,028

+11.58%Advair Diskus$56,263

+4.90%Top Five Sales Losses, Q4 2012Drug Name

Gain ($000)% Change (previous quarter)TriCor-$128,731

-41.58%Neulasta-$29,497

-3.54%Incivek-$26,778

-9.14%One Touch Ultra

-$24,687

-6.59%Avonex-$20,275

-5.17%AbbVie's cholesterol treatment TriCor drops 53 spots with a $129 million sales decline in Q4 2012 even though it did not lose patent protection until January of 2013. Neulasta, Incivek and Avonex also report declining sales of $20 to $30 million.

"The top five brands maintained their leading positions in the last quarter of 2012." said Philip Thornton , CEO of Drugs.com. "Fewer blockbuster brands lost exclusivity, however 2013 will bring a new round of generic competition highlighted by the expected Cymbalta patent loss later this year."

Zomig and Aciphex are additional top-selling brands expected to lose patent protection in 2013.

Detailed data on the top 100 drugs can be accessed at: 
http://www.drugs.com/stats/top100/sales

About Drugs.com

Drugs.com is the leading online drug information resource with over nine million unique visitors per month (ComScore, January 2013). Providing free, independent, peer-reviewed, and up-to-date information at both consumer and professional levels, Drugs.com empowers patients and caregivers to take charge of their health and be more informed than ever before. The site includes many interactive tools and mobile apps to assist consumers, healthcare professionals and researchers, such as personal medication records, a drug interaction checker, pill identification wizard, symptom checker, pharma sales statistics and more.

For more information, visit: www.drugs.com

Media Inquiries: 
Drugs.com Press Officer 
press@drugs.com 
(718) 395 2473

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.

 


'/>"/>
SOURCE Drugs.com
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Latest Drug Sales Data: Loss of Patent Protection Has Significant Effect, According to Drugs.com
2. Drugs.com Releases Q3 Sales for Top 100 U.S. Drugs: Singulair Drops But Nexium and Abilify Remain the Leading Brands
3. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
4. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
5. ShelfX Releases A Fridge That Knows What You Took
6. Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results
7. Stereotaxis Releases V-Sono™ Intracardiac Echocardiography Module for the Vdrive™ Remote Navigation System
8. Simbionix Releases Two New Platforms at the Upcoming DDW and AUA Events
9. Medical Alarm Begins Revenue Recognition from Largest Set of Orders -- Releases New Television Commercial
10. MD Bioproducts releases HLA-B27 subtype specific antibody.
11. ChemDAQ Releases First Sensor For Detection Of Peracetic Acid In Air
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... April 20, 2017 Research and Markets ... Contract Manufacturing Services Market Analysis By Service (Manufacturing, Research), By ... 2014 - 2025" report to their offering. ... The Latin American pharmaceutical contract ... by 2025 Low drug registration cost in Latin ...
(Date:4/19/2017)... 19, 2017 Global Surgical Drainage Device Market: ... used to remove excess liquid and air. The fluid ... bile or lymph. Surgical drains are used in a ... orthopedics surgery, cardiovascular surgery, neurosurgery, plastic surgery etc. Common ... prevent accumulation of fluid e.g. blood or pus. Surgical ...
(Date:4/19/2017)... April 19, 2017 ... immune response in pets such as canine, avian ... of various types such as Attenuated Live Vaccines, ... DNA Vaccines and Recombinant Vaccines. Attenuated live vaccines ... or bacteria, which have been weakend under laboratory ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical organization ... Hospital at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord blood ... , “Women’s Hospital at Renaissance has been a collection partner for the TCBB ...
(Date:4/28/2017)... ... 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, ... to and which He does not. Yisrayl says with so many titles and names ... name, but he says with a little Scripture, backed with a lot of research, the ...
(Date:4/28/2017)... ... April 28, 2017 , ... NuevaCare, a leading home care ... Millbrae, Burlingame, and Palo Alto, is proud to announce information upgrades to its blog ... and read organized content on topics such as home care (generally) as well as ...
(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... ... Economics Insights in Incentives, Rewards, and Recognition: A Nudge Guide," a groundbreaking analysis ... (IRR) field. Offering practical takeaways to apply immediately to IRR programs, the report ...
(Date:4/27/2017)... ... April 27, 2017 , ... SyncDog, Inc. , ... MobileIron Live! 2017 in Santa Clara, California. Each year, MobileIron Live! ... to helping organizations maximize the benefits of mobility in their operations securely. ...
Breaking Medicine News(10 mins):